Evidence map›Paper›PMID 27363023›Full record

ArticleOncotarget2016

Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases.

Eun-Jin Yun, Kyung-Sub Song, Soyeon Shin, Soyeon Kim, Jun-Young Heo, Gi-Ryang Kweon, Tong Wu, Jong-Il Park, Kyu Lim

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Contribution of n-3 Long-Chain Polyunsaturated Fatty Acids to the Prevention of Breast Cancer Risk Factors.International journal of environmental research and public health · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Effect of the Expression ofFrontiers in genetics · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Eun-Jin YunDepartment of Biochemistry, College of Medicine, Chungnam National University, Daejon 301-747, Republic of Korea.
Kyung-Sub SongDepartment of Biochemistry, College of Medicine, Chungnam National University, Daejon 301-747, Republic of Korea.
Soyeon ShinDepartment of Biochemistry, College of Medicine, Chungnam National University, Daejon 301-747, Republic of Korea.
Soyeon KimDepartment of Biochemistry, College of Medicine, Chungnam National University, Daejon 301-747, Republic of Korea.
Jun-Young HeoDepartment of Biochemistry, College of Medicine, Chungnam National University, Daejon 301-747, Republic of Korea.
Gi-Ryang KweonDepartment of Biochemistry, College of Medicine, Chungnam National University, Daejon 301-747, Republic of Korea.
Tong WuDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Jong-Il ParkDepartment of Biochemistry, College of Medicine, Chungnam National University, Daejon 301-747, Republic of Korea.
Kyu LimDepartment of Biochemistry, College of Medicine, Chungnam National University, Daejon 301-747, Republic of Korea.
Chungnam National University · KRTulane University · USThe University of Texas Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is one of the most prevalent cancers in women, and nearly half of breast cancer patients develop distant metastatic disease after therapy. Despite the significant advances that have been achieved in understanding breast cancer metastasis in the past decades, metastatic cancer is still hard to cure. Here, we demonstrated an anti-cancer mechanism of docosahexaenoic acid (DHA) that suppressed lung metastasis in breast cancer. DHA could inhibit proliferation and invasion of breast cancer cells in vitro, and this was mainly through blocking Cox-2-PGE2-NF-κB-MMPs cascades. DHA treatment significantly decreased Cox-2 and NF-κB expression as well as nuclear translocation of NF-κB in MDA-MB-231 cells. In addition, DHA also reduced NF-κB binding to DNA which may lead to inactivation of MMPs. Moreover, in vivo studies using Fat-1 transgenic mice showed remarkable decrease of tumor growth and metastasis to EO771 cells to lung in DHA-rich environment. In conclusion, DHA attenuated breast cancer progression and lung metastasis in part through suppressing MMPs, and these findings suggest chemoprevention and potential therapeutic strategy to overcome malignant breast cancer.

Indexed as

Active Transport, Cell NucleusAnimalsApoptosisBreast NeoplasmsCell Line, TumorCell MovementCell ProliferationCell SurvivalCulture Media, ConditionedCyclooxygenase 2DinoprostoneDisease ProgressionDocosahexaenoic AcidsFemaleGene Expression Regulation, NeoplasticHumansCulture Media, ConditionedCyclooxygenase 2DinoprostoneDocosahexaenoic AcidsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsMMP2 protein, humanMMP9 protein, humanNF-kappa BPTGS2 protein, humanbreast cancerDHAMMPomega-3 PUFA

Identifiers

PMID27363023
PMCPMC5226561
OpenAlexW2474412851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.